1. Show article details.

    BRIEF-Third Point Dissolves Stake In Netflix, Cuts In Baxter, Tradeweb and Adobe

    Reuters – 5:20 PM ET 11/14/2019

    Third Point Llc: * THIRD POINT LLC DISSOLVES SHARE STAKE IN NETFLIX INC - SEC FILING. * THIRD POINT LLC DISSOLVES SHARE STAKE IN TWILIO INC. * THIRD POINT LLC DISSOLVES SHARE STAKE IN ZOOM VIDEO COMMUNICATIONS INC. * THIRD POINT LLC CUTS SHARE STAKE IN BAXTER INTERNATIONAL INC BY 26.7 PERCENT TO 16.9 MILLION SHARES.

  2. Show article details.

    BRIEF-Baxter International Inc - Co Entered Into Amendment No. 2 To Its Existing $1.5 Bln, Five-Year Revolving Credit Agreement, Dated As Of July 1, 2015

    Reuters – 6:27 PM ET 11/06/2019

    Baxter International Inc (BAX): * Baxter International Inc (BAX) - CO ENTERED INTO AMENDMENT NO. * Baxter International Inc (BAX) - AMENDMENT PROVIDES AN EXTENSION OF REQUIRED DELIVERY DATE FOR COMPANY'S QUARTERLY FINANCIAL STATEMENTS TO DECEMBER 31, 2019 Source: Further company coverage:

  3. Show article details.

    Baxter to Present at the Evercore ISI 2nd Annual HealthCONx Conference

    Business Wire – 4:45 PM ET 11/06/2019

    Baxter International Inc. (BAX), a leading global medical products company, will present at the Evercore ISI 2nd Annual HealthCONx Conference in Boston on December 4, 2019. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through June 1, 2020.

  4. Show article details.

    Baxter and Ayogo Launch CKD&Me Patient Empowering Digital Education Tool at Kidney Week 2019

    Business Wire – 8:30 AM ET 11/06/2019

     . DEERFIELD, Ill. This press release features multimedia. CKD&Me supplements the education programs provided by nephrologists and their teams.

  5. Show article details.

    BAXTER INTERNATIONAL INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Baxter International Inc. for Possible Securities Fraud - BAX

    PR Newswire – 10:50 PM ET 11/01/2019

    NEW ORLEANS, Nov. 1, 2019  Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC, announces that KSF has commenced an investigation into Baxter International Inc. (BAX). Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms.

  6. Show article details.

    Baxter to Present at the 28th Annual Credit Suisse Healthcare Conference

    Business Wire – 4:15 PM ET 10/29/2019

    Baxter International Inc. (BAX), a leading global medical products company, will present at the 28th Annual Credit Suisse Healthcare Conference in Scottsdale, Ariz., on November 12, 2019. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through May 10, 2020.

  7. Show article details.

    BRIEF-Baxter International Appoints Karen Leets As Treasurer

    Reuters – 9:45 AM ET 10/28/2019

    Baxter International Inc (BAX): * Baxter International Inc (BAX) - APPOINTS KAREN LEETS AS TREASURER. * Baxter International Inc (BAX) - LEETS MOST RECENTLY SERVED AS ASSISTANT TREASURER, TREASURY OPERATIONS WITH ALPHABET INC. * BAXTER INTERNATIONAL (BAX) - EXPECTS LEETS WILL SERVE IN INTERIM ROLE WHILE SHE ASSISTS CO WITH ONGOING EVALUATION OF INTERNAL CONTROLS, AMONG OTHER THINGS Source: Further company coverage:

  8. Show article details.

    BAXTER INTERNATIONAL INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Baxter International Inc. for Possible Securities Fraud - BAX

    Business Wire – 10:50 PM ET 10/25/2019

    Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC, announces that KSF has commenced an investigation into Baxter International Inc. (BAX). KSF’s investigation is focusing on whether Baxter and/or its officers and directors violated state or federal securities laws.

  9. Baxter stock price target cut to $96 from $105 at SVB Leerink

    MarketWatch – 7:54 AM ET 10/25/2019
  10. Show article details.

    Baxter Probes Accounting Errors in Statements -- WSJ

    DJ Business News – 2:47 AM ET 10/25/2019

    This article is being republished as part of our daily reproduction of WSJ.com articles that also appeared in the U.S. print edition of The Wall Street Journal. Baxter International Inc. (BAX) disclosed errors in its financial statements related to foreign-currency transactions, which may force the company to restate results. Baxter said Thursday that it has hired outside attorneys and consultants to help it with an investigation into the transactions, all of which occurred...

  11. Show article details.

    Hagens Berman, NATIONAL TRIAL ATTORNEYS, Notifies Baxter International (BAX) Investors of Investigation of Possible Securities Fraud: Encourages Investors with Significant Losses to Contact Firm

    PR Newswire – 8:01 PM ET 10/24/2019

    SAN FRANCISCO, Oct. 24, 2019  Hagens Berman notifies Baxter International (BAX) investors of the firm's investigation of possible violations of federal securities laws.

  12. Show article details.

    Medical products maker Baxter launches probe of misstatements in non-operating income, stock slides

    MarketWatch – 11:10 AM ET 10/24/2019

    Medical products company Baxter International Inc. (BAX) said Thursday it has launched an investigation of misstatements in previously reported non-operating income related to foreign exchange gains and losses. Deerfield, Ill.- based Baxter said the investigation involves intra-company transactions undertaken for the purpose of generating forex gains and losses, that used a forex rate convention that did not comply with Generally Accepted Accounting Principles, or GAAP,...

  13. Show article details.

    Baxter International named in opioid complaint by Georgia county

    Reuters – 8:30 AM ET 10/24/2019

    Medical supply company Baxter International Inc (BAX) has been named in a complaint along with other makers and distributors of opioids for improperly marketing the drugs, a filing showed on Thursday.

  14. Show article details.

    Baxter May Amend Five Years of Results After Finding Accounting Error

    DJ Business News – 8:14 AM ET 10/24/2019

    Baxter International Inc. (BAX) said it might need to restate at least five years of results as it has discovered misstatements related to foreign-exchange transactions over the period. The health-products company said Thursday that it had opened an investigation into the transactions, which it said occurred between different parts of Baxter and were undertaken to generate foreign-exchange gains or losses. Shares fell 7% in premarket trading.

  15. Baxter stock down 1.1% premarket

    MarketWatch – 7:23 AM ET 10/24/2019
  16. Baxter sees Q4 sales up 3% to 4%

    MarketWatch – 7:22 AM ET 10/24/2019
  17. Baxter says preliminary results show Q3 revenue up 3% to $2.85 bln

    MarketWatch – 7:22 AM ET 10/24/2019
  18. Baxter does not expect to file September quarter 10-Q in a timely manner

    MarketWatch – 7:21 AM ET 10/24/2019
  19. Baxtter says have voluntarily informed the SEC of investigation

    MarketWatch – 7:21 AM ET 10/24/2019
  20. Baxter says forex rate used in intra-company transactions was not in accordance with GAAP rules

    MarketWatch – 7:20 AM ET 10/24/2019
Page:

Today's and Upcoming Events

  • Feb
    06

    BAX to announce Q4 earnings (Confirmed)

Past Events (last 90 days)

  • Oct
    24

    BAX announced Q3 earnings.

  • Aug
    29

    BAX ex-Dividend for $0.22 on 08/29/2019

    • Announce Date: 07/16/2019
    • Record Date: 08/30/2019
    • Pay Date: 10/01/2019
Data provided by Thomson Reuters © 2019

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.